Global /China /Healthcare /Drug Manufacturers - General /300636

Jiangxi Synergy Pharmaceutical Co., Ltd.

300636

• SHE: 300636 • Delayed

7.82CNY 0.6%

1.16 USD

As of 15 June 2026, Jiangxi Synergy Pharmaceutical Co., Ltd. has a market cap of $485.27M USD, ranking #15335 globally and #4793 in China. It ranks #1365 in the Healthcare sector, and #503 in the Drug Manufacturers - General industry.

Global Rank

15335

Country Rank

4793

Sector Rank

1365

Industry Rank

503

Key Stats

Market Cap

$485.27MUSD

3.28B CNY

Enterprise Value

$536.04MUSD

3.63B CNY

Revenue (TTM)

$122.45MUSD

828.66M CNY

EBITDA (TTM)

$37.97MUSD

256.94M CNY

Net Income (TTM)

$10.8MUSD

73.09M CNY

EBITDA Margin

31%

Profit Margin

8.8%

PE Ratio

44.9

PS Ratio

4.0

PB Ratio

1.4

EV/EBITDA

14.1

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Zhengwei Pang open_in_new

Employees

1,418

Founded

2004

Website

jxsynergy.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.6%	-2.1%	-1.9%	-5.2%	-5.4%	3.5%	14%	-42%	-35%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300636 江西同和药业股份有限公司 Class A ISIN: CNE100002P83 Shares Out.: Shares Outstanding: 419.952M¹ Shares Float: 419.952M² TV: TradingView: SZSE: 300636 SA: Stock Analysis: SHE: 300636 YF: Yahoo Finance: 300636.SZ GF: Google Finance: SHE: 300636 BA: Barron's: 300636 MS: Morningstar: XSHE: 300636	7.82 CNY	TV: TradingView: SZSE: 300636 SA: Stock Analysis: SHE: 300636 YF: Yahoo Finance: 300636.SZ GF: Google Finance: SHE: 300636 BA: Barron's: 300636 MS: Morningstar: XSHE: 300636

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Jiangxi Synergy Pharmaceutical Co., Ltd.

Jiangxi Synergy Pharmaceutical Co., Ltd. engages in research and development, production, and sales of chemical raw materials and pharmaceutical intermediates in China and internationally. The company offers nervous system drugs, digestive system medications, antipyretic analgesics and non-steroidal anti-inflammatory analgesics, antihypertensive drugs, anticoagulants, hypoglycemic drugs, antidepressants, as well as antigout and urinary system medications. It also exports its products to Europe, the United States, Japan, South Korea, and other regions. Jiangxi Synergy Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Yichun, the People’s Republic of China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.92B 364.89B CNY 11K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.7B 336.36B CNY 10K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 6K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 4K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.53B 111.89B CNY 3K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 3K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 157K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 113K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 74K%	97.4	United States
Roche Holding AG SIX: RO	$320.51B 256.25B CHF 66K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.14B 215.59B GBP 59K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 56K%	15.1	United States

chevron_leftBack